Serina Therapeutics, Inc. (SER)

NYSEAMERICAN: SER · Real-Time Price · USD

1.900

-0.020 (-1.04%)

At close: Jul 2, 2026, 4:00 PM EDT

1.900

0.00 (0.00%)

After-hours: Jul 2, 2026, 8:00 PM EDT

Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.53	3.06	3.67	7.62	0.65	0.58
Cash & Short-Term Investments	24.53	3.06	3.67	7.62	0.65	0.58
Cash Growth	474.78%	-16.78%	-51.80%	1081.24%	10.45%	10.82%
Accounts Receivable	-	-	-	-	0	0.03
Other Current Assets	1.95	3.02	2	-	1.8	1.63
Total Current Assets	26.47	6.08	5.68	7.62	2.45	2.23
Net Property, Plant & Equipment	0.8	0.84	1.05	1.35	-	-
Other Intangible Assets	-	-	-	-	0.74	0.87
Other Long-Term Assets	0.03	0.03	-	-	0.05	0.05
Total Assets	27.3	6.95	6.72	8.97	3.24	3.15
Accounts Payable	2.83	1.93	0.74	0.58	1.03	0.77
Accrued Expenses	1.51	1.21	1.43	0.58	-	-
Current Portion of Long-Term Debt	-	-	-	-	7.65	7.14
Other Current Liabilities	2	0.43	0.19	0.25	1.4	1.06
Total Current Liabilities	6.34	3.56	2.37	1.41	10.08	8.97
Long-Term Debt	3.01	2.95	-	2.98	10.48	6.06
Long-Term Leases	0.16	0.2	0.27	0.46	-	-
Other Long-Term Liabilities	0.16	0.28	3.58	-	-	-
Total Long-Term Liabilities	3.33	3.43	3.85	3.45	10.48	6.06
Total Liabilities	9.67	6.99	6.22	4.86	20.56	15.03
Preferred Stock	4.94	4.94	-	-	-	-
Common Stock	0	0	0	-	-	0
Additional Paid-in Capital	83.09	58.54	44.96	0.88	99	93.91
Accumulated Other Comprehensive Income	-0.01	-0.01	-	-	-	-
Retained Earnings	-70.4	-63.5	-44.32	-33.18	-116.21	-105.75
Total Common Shareholders' Equity	17.63	-0.04	0.64	-32.29	-17.21	-11.83
Minority Interest	-	-	-0.13	36.4	-0.1	-0.04
Shareholders' Equity	17.63	-0.04	0.51	-32.29	-34.53	-11.88
Total Liabilities & Equity	27.3	6.95	6.72	8.97	3.24	3.15
Total Debt	3.17	3.14	0.27	3.45	18.12	13.2
Net Cash (Debt)	21.36	-0.09	3.4	4.17	-17.48	-12.62
Net Cash Growth	-	-	-18.45%	-	-	-
Net Cash Per Share	1.98	-0.01	0.46	0.57	-8.15	-11.71
Book Value	17.63	-0.04	0.64	-32.29	-17.21	-11.83
Book Value Per Share	1.64	-0.00	0.09	-4.39	-8.02	-10.98
Tangible Book Value	17.63	-0.04	0.64	-32.29	-17.95	-12.7
Tangible Book Value Per Share	1.64	-0.00	0.09	-4.39	-8.37	-11.79

SEC Filings: 10-K · 10-Q